ESLA
Estrella Immunopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.26
+0.01 ▲ +0.80%
🌙 3월 13일 4:33 PM ET (한국 3/14 05:33)
$1.24
-0.02 ▼ -1.57%
| Index | - | P/E | - | EPS (ttm) | -0.37 | Insider Own | 62.05% | Shs Outstand | 0.04B | Perf Week | 17.76% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.02B | Perf Month | -3.08% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.13 | Inst Own | 2.5% | Short Float | 4% | Perf Quarter | -39.42% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 1.3% | Short Ratio | 3.52 | Perf Half Y | 21.15% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -371.99% | Short Interest | 0.64M | Perf YTD | -19.23% |
| Book/sh | -0.26 | P/C | 32.49 | EPS past 3/5Y | -78.83% - | ROE | -314.6% | 52W High | -60% ($3.15) | Perf Year | 23.53% |
| Cash/sh | 0.04 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 72.58% ($0.73) | Perf 3Y | -88.26% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -51.97% | Gross Margin | - | Volatility(W/M) | 13.14% 10.94% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.14 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.15 | EPS Q/Q | -38.69% | Profit Margin | - | RSI (14) | 55.68 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.15 | Sales Q/Q | - | SMA20 | 6.08% ($1.19) | Beta | 0.51 | Target Price | $8 |
| Payout | - | Debt/Eq | - | Earnings | 2026/02/25 | SMA50 | 6.76% ($1.18) | Rel Volume | 0.12 | Prev Close | $1.25 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -3.93% ($1.31) | Avg Volume(3M) | 0.18M | Price | $1.26 |
| IPO | 2021/9/14 | Option/Short | No/Yes | Trades | 293 | Volume | 22,067 | Change | 0.8% |
뉴스 로딩 중...